Intrinsic Value of S&P & Nasdaq Contact Us

Evotec SE EVO NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • DE • USD

SharesGrow Score
48/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$7.00
+118.1%

Evotec SE (EVO) has 7 known insider and institutional holders on record. The largest holder is Zientek Michael with 200,000 shares. Other notable holders include Smith Scott Clifford and Anderson Mark Monroe.

EVO Insider Ownership

Top Holder
Zientek Michael
200,000 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Zientek Michael Chief Financial Officer 200,000 2018-10-02
100%
2 Smith Scott Clifford Director 100,000 2018-10-29
50%
3 Anderson Mark Monroe Director 100,000 2018-11-01
50%
4 Laffer Arthur B Director 100,000 2018-10-12
50%
5 Ubs Ag 10 Percent Owner 531 2009-02-10
0%
6 Ubs Group Ag 10 Percent Owner 531 2014-12-02
0%
7 Bank Of America Corp /de/ 10 Percent Owner 96 2009-02-10
0%

No ownership data available for EVO.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message